New Stock News | Archeron Submits Application to Hong Kong Stock Exchange as Leading Early Cancer Detection Company

According to the Wise Finance APP, it was learned that on September 28, the Hong Kong Stock Exchange disclosed that Wuhan Amyson Life Science and Technology Co., Ltd. (referred to as "Amyson") submitted an application for listing on the main board of the Hong Kong Stock Exchange, with joint sponsors being CIMB International and CCB International.